Carter Bankshares (CARE) Q4 2022 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2022 earnings summary
5 Nov, 2026Executive summary
Net income was $50.1 million, or $2.03 diluted EPS, in 2022, versus $31.6 million, or $1.19, in 2021; higher net interest income drove the improvement.
Strategic priorities shifted toward organic growth, loan and deposit growth, fee income, expense discipline and selective, opportunistic acquisitions.
Financial highlights
Net interest income rose $28.7 million, or 25.9%, to $139.9 million in 2022; provision for credit losses fell $0.9 million to $2.4 million.
Noninterest income decreased $7.2 million to $21.7 million, mainly as securities gains fell; noninterest expense declined $5.3 million to $97.0 million.
Income tax expense increased to $11.6 million from $4.1 million; the effective tax rate was 18.8% versus 11.5%, reflecting higher pretax income and lower tax benefits.
Total assets increased 1.7% to $4.2 billion; portfolio loans grew 12.0% to $3.1 billion, while deposits declined $68.2 million to $3.6 billion.
Outlook and guidance
The 2023–2025 strategy emphasizes organic growth, with consideration of acquisitions that fit the strategic direction; a refreshed mission, vision and values were planned for rollout in 2023.
Higher mortgage rates were expected to moderate residential mortgage growth; management also cautioned that some elevated loan pricing may not recur and funding costs may rise.
Management expected higher short-term rates to improve yields on some variable-rate securities over the next six to twelve months.
Latest events from Carter Bankshares
- A $301.9M nonaccrual relationship drove 8.83% NPLs and a Q4 loss.CARE
Q4 2023 - NIM expansion and loan growth offset elevated quarterly credit costs.CARE
Q3 2026 - Net income surged on nonrecurring gains, with improved asset quality and capital ratios.CARE
Q2 2026 - Earnings surged in Q1 2026 on a major loan sale, sharply improving capital and asset quality amid new legal risks.CARE
Q1 2026 - Director elections, executive pay, auditor ratification, and ESG priorities headline the 2026 proxy.CARE
Proxy filing - Votes will be cast on director elections, executive pay, and auditor ratification for 2026.CARE
Proxy filing - Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 2025 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 2025